NCT00004488View on ClinicalTrials.gov

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

September 30, 2002

Conditions
Gaucher's DiseaseOsteopenia
Interventions
DRUG

alendronate sodium

DRUG

calcium carbonate

DRUG

cholecalciferol

Trial Locations (3)

45401

Wright State University School of Medicine, Dayton

91031

Shaare Zedek Medical Center, Jerusalem

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00004488 - Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease | Biotech Hunter | Biotech Hunter